Respiratory Infections News

The FDA authorized a third dose of COVID-19 vaccine for certain immunocompromised patients but continued to say that other fully vaccinated people do not need a booster.

Patients who are immunocompromised may soon be eligible to receive a booster dose of COVID-19 vaccine in the United States.

Phase 2/3 data now published in The New England Journal of Medicine showed that the Moderna COVID-19 vaccine was safe and generated strong activity against SARS-CoV-2 in adolescents, with an immune response similar to that of young adults.

Humanigen has announced that its antibody lenzilumab increased the likelihood of survival among certain Black and African American patients with COVID-19.

Computerized versions of the Pneumonia Severity Index accurately identified patients with community-acquired pneumonia at low risk for death, according to data published in the Annals of the American Thoracic Society.

The CDC encouraged pregnant and breastfeeding women to get vaccinated against COVID-19 as researchers from the agency reported what they called “reassuring” data Wednesday on the safety of the vaccines.

The AAP published interim guidance on the treatment of lower respiratory tract infections caused by respiratory syncytial virus amid an offseason surge in cases that has corresponded with the relaxation of some COVID-19 restrictions.

A phase 2 trial sponsored and funded by the NIH’s National Institute of Allergy and Infectious Diseases will assess the antibody response of a third dose of COVID-19 messenger RNA vaccine in kidney transplant recipients.

Immunization with recombinant quadrivalent influenza vaccines improved antibody responses at 1 month after vaccination compared with egg-based vaccines in a randomized trial conducted among health care personnel.

New study data show that vaccination offers better protection against COVID-19 than prior infection, the CDC said Friday.